EN - Malopolska Medical Center in Krakow, screening to qualify for clinical trials, a drug called LOXO-305 ( https://www.loxooncology.com/pipeline/loxo-305-btk-inhibitor ). Blood tests, ECG, trepanobiopsy, computed tomography. Test results in three weeks, if the screening test is successful, treatment will begin. ( https://investor.lilly.com/news-releases/news-release-details/lilly-presents-interim-clinical-data-loxo-305-dose-escalation )
PL - Małopolskie Centrum Medyczne w Krakowie, badania przesiewowe celem kwalifikacji do badań klinicznych, lek o nazwie LOXO-305 ( https://www.loxooncology.com/pipeline/loxo-305-btk-inhibitor ). Badania krwi, EKG, trepanobiopsja, tomograf komputerowy. Wyniki badań za trzy tygodnie, jeżeli badania przesiewowe wyjdą prawidłowo to rozpocznie się leczenie ( https://investor.lilly.com/news-releases/news-release-details/lilly-presents-interim-clinical-data-loxo-305-dose-escalation )
Subskrybuj:
Komentarze do posta (Atom)
VI cycle of clinical trials with LOXO-305. VI cykl badań klinicznych lekiem LOXO-305.
EN - The 6th treatment cycle lasts: HGB - 9.6 (on July 24 it was 14.2); WBC - 2.58 (was 15.4); PLT - 72 (was 54); IgM - 2.24 g / l (was 9.6...
-
EN - 16 times at the doctor, from the end of immunochemotherapy on 24 October 2012. It was so beautiful !!! Unfortunately, the disease did ... -
EN - I wonder if the natural treatment does not help me faster than the treatment in the hospital. Or you can combine them toget... -
EN - March 12, 2020, further follow-up tests, no IgM tests yet, but good morphology, platelets above 100. The drug apparently works, first a...
Brak komentarzy:
Prześlij komentarz